A study to evaluate the effect of Laaja saktu in management of Urdhwag Amlapitta in 60 participants.

A randomised control trial to evaluate the effect of Laaja Saktu in the management of Urdhwaga Amlapitta. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088225

Enrollment

Registered

2025-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Recently diagnosed patients with Urdhwag Amlapitta

Exclusion criteria

Exclusion criteria: Diabetic patients Patients with severe vomiting and diarrhea Chronic disease like HIV, Tuberculosis and gastric ulcer Pregnant and lactating mothers Patients with drug induced hyperactivity

Design outcomes

Primary

Measure	Time frame
To study the effect of lajasaktu in the management of Urdhwag Amlapitta.Timepoint: The parameters of efficacy of lajasaktu will be evaluated by observing patients through subjective criteria at regular intervals 0th,7th, 14th days follow up. The relief of sign and symptoms of Amlapitta will be evaluated with the help of questionnaire.	—

Secondary

Measure	Time frame
To prepare and standardize lajasaktu. To study effect of lajasaktu on Amlapitta.Timepoint: The parameters of efficacy of lajasaktu will be evaluated by observing patients through subjective criteria at regular intervals 0th,7th, 14th days follow up. The relief of sign and symptoms of Amlapitta will be evaluated with the help of questionnaire.	—

Countries

India

Contacts

Public ContactDr Ramesh Ujwale

MAMs Sumatibhai Shah Ayurved Mahavidyalay, Hadapsar

ujwale_rs@rediffmail.com9922008027

Outcome results